According to a recent publication by Meticulous Research®, the protein expression market is expected to reach $5 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period. This growth is primarily driven by the expanding biopharmaceutical sector, increasing demand for recombinant proteins, a surge in cell-based research, the rising prevalence of chronic diseases, advancements in molecular and cellular technologies that enhance bioproduction, and increasing government support and funding for life science research.
Moreover, emerging economies and the development of point-of-care (POC) technologies are anticipated to present significant growth opportunities for the protein expression market. However, challenges such as the high cost of protein-based research and a shortage of skilled professionals may hinder market growth. Additionally, complexities associated with laboratory transformation parameters pose further challenges for this market.